Case File
efta-efta01187601DOJ Data Set 9OtherDS9 Document EFTA01187601
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01187601
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To:
Cc:
Subject:
Attachments:
Inline-Images:
Tazia Smith •t:
>
[email protected]
Paul Morrie
a
Vahe
Stepanian
Alternative Asset Manager Autocallable Snowball Coupon/Barrier [C]
Thu, 20 Feb 2014 15:01:25 +0000
Alternative_Asset_Managers_1.28.14.pdf
unnamed; unnamed(1); unnamed(2); unnamed(3)
Classification: Confidential
* * DB Key Client Partners: Email prepared exclusively for Jeffrey Epstein • *
Good Morning Jeffrey-
Consider the below as part of the Financials segment within your allocation. Like your Apollo shares, the broader Alternative Asset
Manager group has benefitted from a gearing to rising asset prices; strong performance on underlying funds are translating to
performance return participation and greater the earnings at the company level, not to mention that meaningful inflows to alternative
investments are leading to increased AUM fee collection.
I like this structure below. The underlying companies (Blackstone and Carlyle) may have run, but earnings outlook appears solid and this
structure is a way to monetize vol with an attractive risk/return profile.
Base case of getting called in year-one with a 25% coupon and having that 35% downside protection. Downside participation if the worst-
of breaches the 65% barrier; max loss 100%.
Issuer:
Structure:
Underlyings:
Tenor:
DIP Barrier:
KO Barrier:
Redemption Barrier:
Snowball Coupon:
Autocall:
Max Gain:
75% over 3yrs (25% p.a.)
Max Loss:
100%
DB
Knock In - Knock Out Barrier Note with Snowball Coupon
Worst of BX US and CG US
3 Yrs
65% (European)
112% (if worst-of is above KO Barrier on any day then DIP knocks out and note becomes principal protected)
100% (autocalled if both underliers are above initial level upon annual observation)
25% p.a. (snowballing, client can receive up to 75% coupon over 3yrs...50% y2 if not called, 75% if matures)
Annual observation, if both underliers are > initial level at annual observation
Indicative levels only, subject to market movement. Source: DB GM Structuring, as of 2/12/14.
BX 1yr Price History
EFTA01187601
I BX US
I
Market
Low.•—•••••-r".
P31..40 /31..63K
S x2
..i.
Prev 31.37
Vol 6,445
Malli
tlia
Save As
90 Actions
PI car
1D
3D
1/1
641
YTD
rt
5Y
Max
Daily •
+ Track
Lase once
• Last Price
1
31.37
T High on 01/22/14 33.19
-9- Average
24.4492
1 Low on 02/26/B 18.43
-
91) Ech
cn ve
err.. nms mmm
•
a" Security/Study
II Event
0
I
Annotate
News
Zoom
Mar
Jun
2013
35-13
AIM
2014
CG tyr Price History
eSi Save As
AO Actions
IEEE=" in
Pi
17)
3C
LM
6M
YTD .1Y
SY
Max
Daily •
E • Last Price
35.90
T High on 01/14/14 37.91
-9- Average
30.3176
1. Low on O6/24/13 24.19
V
Used with permission of Bloomberg Finance LP
-.2 al the Alternative Asset Managers; BX is top pick
We initiate coverage of 5 alternative asset managers (the "Alit) with Buys on
Blackstone (BX). Carlyle Group (CG), & Oaknee Capital (OAK) & Hold ratings on
Apollo Global Mgmt (APO) & KKR & Co (KKR). Overall, these Alts are welipositioned
amid favorable cyclical tailwinds & strong secular dynamics, while
valuations remain attractive. We favor the more-diversified Alts possessing less
earnings variability & good distributable earnings (DE) growth profiles for 2014-
2015; this dynamic favors BX & CG over APO & KKR for now, in ow view. & we
see 4Q earnings as a positive catalyst upon a better DE outlook for next 1-2
years. We also like OAK's more-traditional asset manager business profile.
Valuations still alliaclise as debate on s al Lan5 the Alts ownUwe,
With volatile and less predictable earnings, the market has been reluctant to
EFTA01187602
assign a comparable traditional asset manager PPE on the Alts' carried interest
income stream, which accounted for over half of Alt's pretax income over the
past 2 years. However, we see limitations in this legacy sum-of-parts valuation
approach (valuing fee-earnings at much higher multiples than carried interest)
primarily because of the longer-term reliability of carried interest convening
into cash distributions for public unit holders. Thus. we prefer to value the Alts
on longer-tear 'distributable earnings' (DE). which is a proxy for cash flow and
the basis for cash distributions to unit holders. On this approach, we think
these 5 Alt managers can trade at a median 12-13x P/E on our 2015 DE
forecasts, a year from now, which implies about 2 points of multiple expansion
and over 15% price appreciation, and about 22% total return inclusive of
median 6-7% distribution yields at current price levels.
Roth cyclical and SO:Illar themes are eery
In the currant economic/capital markets cycle, the Alts are likely to increasingly
benefit from realizing the value of their long-term investments (from sales via
M&A, IPOs, etc.) and distributing more cash to unit holders over 2014-15.
Thus, we sec a greater convergence of DE and the more volatile mark-tomarket-
driven economic net income (EN1), as the realization cycle gains
momentum in 2014. Asset organic growth rates should remain healthy as
strong investment performance track records enable fundraising to outpace
outflows from realized distribution to LPs. Key secular trends favoring Alts are
I) rising allocations globally to alternative assets by institutions, and
increasingly, individuals. 2) a major competitive advantage in ability to
generate patient capital and invest long-term and influence investment
outcomes. 3) a greater role for Alts in financing. creating more capital
deployment opportunities globally, & 4) increasing concentration of asset flows
to the largest Alts, which favors these 5 stocks.
Tazia Smith
Director I Key Client Partners - US
Deutsche Bank Securities Inc
Deutsche Asset 71 Wealth Management
345 Park Avenue. 26th Floor
New York, NY 10154
Pan-io-4..fr Peiferein
This communication may contain confidential and/or privileged information.
If you are not the intended recipient (or have received this communication
in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the
material in this communication is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
This communication may contain confidential and/or privileged information.
If you are not the intended recipient (or have received this communication
in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the
material in this communication is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
EFTA01187603
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.